We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




PEPFAR and BD Improve African Blood Collection Safety

By LabMedica International staff writers
Posted on 18 Aug 2009
United States officials have signed a partnership agreement with Becton, Dickinson and Company (BD; Franklin Lakes, NJ, USA), launching an initiative to improve blood collection safety in clinics and hospitals in sub-Saharan Africa. More...
The aim of the pact is to protect healthcare personnel and patients in African countries from infectious agents such as human immunodeficiency virus (HIV) that are transmitted by blood.

A Memorandum of Understanding was signed in Washington on August 11, 2009 by Ambassador Elizabeth Bagley, the U.S. Department of State special representative for global partnerships (Washington DC, USA), and Gary M. Cohen, executive vice president of BD.

Safer blood collection has become critical in sub-Saharan nations and other emerging African countries, which are severely impacted by the HIV/AIDS pandemic. Access to HIV treatment in these countries significantly increased in recent years and consequently has expanded the quantity of blood drawing for HIV screening and monitoring tests.

The three-year initiative--which may be extended up to two additional years--is scheduled to begin in Kenya and expand to include up to four additional U.S. President's Emergency Plan for AIDS Relief (PEPFAR)-supported countries. It will ultimately support in-service training for as many as 10,000 healthcare workers. When fully implemented, the monitoring component of the initiative aims to track as many as two million blood-draws within each participating country.

''The program will help hospital and clinical personnel improve their blood-drawing procedures and specimen handling, processes that are critical to the proper management of HIV/AIDS patients,'' said the State Department (Washington DC, USA) release. In addition, "… [it] will help prevent needle stick injuries by establishing or enhancing needle stick-injury surveillance. These monitoring measures can identify practices that pose risks to health workers and patients.''

Ministries of Health in participating countries will develop individualized policies, guidelines, and standard operating procedures for blood drawing and specimen handling.

Related Links:
U.S. Global Partnership Initiative, the Department of State
Becton, Dickinson and Company
PEPFAR


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Molecular Diagnostics

view channel
Image: Skin samples from people with a suspected genetic myopathy were examined for confirmation of disease. Brown spots show abnormal protein buildup inside the nuclei of cells (purple), typical of a type of myopathy called oculopharyngodistal myopathy. (Image Credit: Garvan Institute)

Long-Read Sequencing Test Identifies Genetic Causes in Inherited Muscle Disease

Inherited muscle diseases are highly heterogeneous and often progressive, leaving many patients without a molecular diagnosis despite extensive testing. Conventional assays typically target individual... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.